P. aeruginosa Resistance May Be Measure of Ability to Hijack CF Mucus
cystic fibrosis
Pel, a complex sugar molecule produced by Pseudomonas aeruginosa, contributes to the bacterium’s ability to aggregate and resist both antibiotics and mucus thinners in people with cystic fibrosis (CF) by binding to an ... Read more